Together, we have identified the CDK8-CycC complex as a novel downstream effector of the mTORC1 signaling and our results suggest an important role of the mTORC1/CDK8 pathway in the development of NAFLD. This evidence concerns the gene CDK8 and metabolic dysfunction-associated steatotic liver disease.